Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
Researchers are looking for new ways to treat people with high-risk muscle-invasive urothelial carcinoma (MIUC). Urothelial carcinoma is a type of bladder cancer that begins in cells that line the inside of the bladder and other parts of the urinary tract, such as part of the kidneys, ureters, and urethra. People with MIUC usually have chemotherapy before surgery, then surgery to remove the cancer. Chemotherapy is a type of medicine to destroy cancer cells or stop them from growing. After surger
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this bladder cancer clinical trial in Philadelphia, PA
If you're searching for bladder cancer treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.